🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› New Westminster
Clinical trial register · Canada

Clinical Trials in New Westminster, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6540 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:55 UTC
6540
Studies in scope
all four open statuses
3515
Recruiting now
open to new participants
887
Lead sponsors
across recruiting studies
Top sites
Toronto 2809 Montreal 1902 Vancouver 1179 Calgary 1061 Edmonton 1017
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie8 Janssen Research & Development, LLC6 Fraser Orthopaedic Research Society4 McMaster University3 AstraZeneca3
Site location
Toronto2809 Montreal1902 Vancouver1179 Calgary1061 Edmonton1017
All 255 locations
Target enrolment
to

Trials with a site in New Westminster

70 of 6540 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Brain-based Prediction of the Dying Duration in Humans After Withdrawal of Life Sustaining Therapies to Inform Donation After Circulatory Death
NCT07698262Organ Donation After Circulatory Death
University of British Columbia
Observational
102
Calgary, Cranbrook, Kelowna, New Westminster, Surrey, Vancouver, Winnipeg, London
2027-01
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
NCT07754461Type 2 Diabetes
DrugSurvodutide
Boehringer Ingelheim
Phase 3
600
New Westminster, Brampton, Concord, Nepean, Toronto, Montreal, Québec
2026-08-24
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
NCT07784725Obesity or Overweight
DrugAZD6234
AstraZeneca
Phase 3
2,500
Calgary, New Westminster, Surrey, Victoria, Moncton, Truro, Brampton, Guelph
2026-08-19
Not yet open
ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT07687056Stroke, Acute Ischemic, Endovascular Thrombectomy, Acute Ischemic Stroke AIS
DrugTenecteplase
University of Calgary
Phase 3
1,500
Calgary, Edmonton, Kelowna, New Westminster, Vancouver, Winnipeg, Greater Sudbury, Ottawa
2026-06-10
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184944Crohn's Disease
DrugDuvakitug
Sanofi
Phase 3
751
Hamilton, London, New Westminster, Toronto
2026-01-22
Not yet open
Single-dose Prophylactic INdomethacin in Extremely Preterm Infants
NCT06572917Extreme Prematurity, Intraventricular Hemorrhage, Morbidity;Newborn
DrugIndomethacin
University of British Columbia
Phase 2
500
Calgary, Edmonton, New Westminster, Vancouver, Halifax, Toronto, Montreal, Québec
2025-11-01
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184931Crohn's Disease
DrugDuvakitug
Sanofi
Phase 3
980
Oakville, Brampton, Edmonton, Greater Sudbury, Hamilton, London, Montreal, New Westminster
2025-10-01
Recruiting
Single vs. Dual Implant Fixation for Distal Femur Fractures in Older or Compromised Adults
NCT06944964Distal Femur Fractures
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicable
44
New Westminster, London
2025-09-01
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
NCT07136012Cardiovascular Disease
DrugOlpasiran
Amgen
Phase 3
11,000
Calgary, Edmonton, New Westminster, Surrey, Vancouver, Victoria, Brampton, Burlington
2025-08-22
Recruiting
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
NCT07112339Diabetes Mellitus, Type 2
DrugInsulin icodec
Novo Nordisk A/S
Phase 4
586
Calgary, Edmonton, New Westminster, Winnipeg, Moncton, Brampton, Burlington, Concord
2025-08-15
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
11,800
Calgary, Red Deer, Kelowna, New Westminster, North Vancouver, Penticton, Surrey, Moncton
2025-07-22
Active, closed
Optimizing Patient-centred Outcomes Using Opioid Minimization Strategies: The OPUS Anesthesia Pilot Trial
NCT06884540Anesthesia, Anesthesia Complication, Surgery, Quality of Life
DrugsLidocaine·Dexmedetomidine
CHU de Quebec-Universite Laval
Not applicable
100
New Westminster, Toronto, Lévis, Montreal, Québec
2025-07-15
Recruiting
A Novel Blood Test as a Biomarker in Mental Health
NCT06856161Depression - Major Depressive Disorder, Schizophenia Disorder, Psychosis, Mania (Neurotic)
Fraser Health
Observational
500
New Westminster
2025-03-25
Active, closed
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT06864988Macular Neovascularization Secondary to Age-Related Macular Degeneration
DrugsEYLEA (aflibercept)·4D-150 IVT
4D Molecular Therapeutics
Phase 3
480
Calgary, New Westminster, North York, Ottawa
2025-03-03
Recruiting
Early Fixation for Diaphyseal Humeral Shaft Fractures in the Elderly Patients
NCT06605482Humerus Shaft Fracture, Elderly (People Aged 65 or More)
Fraser Orthopaedic Research Society
Observational
94
New Westminster
2024-11-07
By invitation
Long-term Follow up of the Stability 1 Trial
NCT06885372LET, ACL Reconstruction, Osteoarthritis (OA) of the Knee
Western University, Canada
Not applicable
510
Banff, Calgary, New Westminster, Winnipeg, Hamilton, Kingston, London
2024-11-01
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698Liver Diseases, Alcoholic
DrugGSK4532990
GlaxoSmithKline
Phase 2
393
Calgary, New Westminster, Vancouver, London, Toronto, Montreal, Terrebonne
2024-09-27
Recruiting
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT06320431Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic
DrugTenecteplase
University of Calgary
Phase 3
4,000
Calgary, Medicine Hat, Red Deer, Edmonton, Kelowna, New Westminster, Vancouver, Brandon
2024-09-26
Recruiting
Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery
NCT05824338Anesthesia, Spinal, Neurosurgery, Ropivacaine, Bupivacaine
Fraser Health
Phase EARLY_PHASE1
45
New Westminster, Port Moody
2024-08-27
Recruiting
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
NCT06096116Acquired Antithrombin Deficiency
Octapharma
Phase 3
120
New Westminster, Kingston, Toronto, Montreal
2024-08-21
Active, closed
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
NCT06534892Respiratory Syncytial Virus Infections
DrugRSVPreF3 OA vaccine
GlaxoSmithKline
Phase 3
10,212
Edmonton, New Westminster, Surrey, Vancouver, Victoria, Halifax, Truro, Greater Sudbury
2024-08-01
Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
NCT06430801Crohn's Disease
DrugTulisokibart
Merck Sharp & Dohme LLC
Phase 3
1,200
Calgary, Edmonton, Lethbridge, New Westminster, Vancouver, Kentville, Barrie, London
2024-06-05
Active, closed
Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective
NCT06322537Cardiovascular Surgical Procedures, Albumin
University Health Network, Toronto
Observational
505
New Westminster, Vancouver, Halifax, Hamilton, Kingston, London, Ottawa, Toronto
2024-05-23
Recruiting
HIP Fracture Oral ThromboPROphylaxis (Hip PRO Pilot)
NCT05775965Hip Fractures
DrugsAcetylsalicylic acid ASA·Rivaroxaban·Aspirin
University of Calgary
Phase 2
250
Calgary, New Westminster, Ottawa
2024-05-21
Active, closed
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
NCT06294925Colitis, Ulcerative
DrugEtrasimod
Pfizer
Observational
360
Kelowna, New Westminster, Richmond, Vancouver, London, Ottawa, Montreal
2024-05-08
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
NCT06307652Heart Failure and Impaired Kidney Function
AstraZeneca
Phase 3
3,850
New Westminster, North Vancouver, Vancouver, Winnipeg, Sydney, Cambridge, Hamilton, London
2024-04-12
Active, closed
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
NCT06254950Ulcerative Colitis
DrugZasocitinib
Takeda
Phase 2
213
Calgary, New Westminster, London, Montreal
2024-03-29
Recruiting
LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
NCT05879432Acute Kidney Injury, Cardiac Surgery
Arch Biopartners Inc.
Phase 2
240
Calgary, New Westminster, Toronto
2024-03-08
Recruiting
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461Crohn's Disease
DrugZasocitinib
Takeda
Phase 2
268
Calgary, New Westminster, Halifax, London, Toronto, Montreal
2024-03-05
Active, closed
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
NCT06292013Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
DrugLepodisiran
Eli Lilly and Company
Phase 3
17,300
Brampton, Chicoutimi, Hamilton, Joliette, London, Longueuil, Moncton, New Westminster
2024-03-05
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
NCT06030063Cesarean Delivery, General Anesthesia
Yale University
Observational
5,000
New Westminster
2024-02-22
Active, closed
Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.
NCT05930275Crohn's Disease
AbbVie
Observational
1,200
Calgary, Edmonton, New Westminster, Winnipeg, Halifax, Barrie, London, Mississauga
2024-02-19
Active, closed
The PEERLESS II Study
NCT06055920Pulmonary Embolism
Inari Medical
Not applicable
1,200
New Westminster, Surrey, Vancouver
2023-11-17
Recruiting
Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy
NCT05615844Open tíbia Fracture
University of Maryland, Baltimore
Phase 3
312
New Westminster, Vancouver, Hamilton, London, Ottawa
2023-11-05
Active, closed
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT06052059Ulcerative Colitis
DrugTulisokibart
Merck Sharp & Dohme LLC
Phase 3
1,020
Calgary, Edmonton, Lethbridge, New Westminster, Vancouver, Kentville, Barrie, London
2023-10-25
Recruiting
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
NCT05114096Preterm Birth, Premature Birth, Complication of Prematurity, Obstetric Labor, Premature
McMaster University
Phase 4
3,254
Calgary, Edmonton, New Westminster, Surrey, Vancouver, Victoria, Winnipeg, Fredericton
2023-07-20
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
NCT05427370Coronary Artery Disease, Heart Failure Systolic
Sunnybrook Health Sciences Centre
Not applicable
754
Calgary, Edmonton, New Westminster, Vancouver, Winnipeg, Halifax, Hamilton, London
2023-06-22
Active, closed
An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
NCT05841537Crohn's Disease
AbbVie
Observational
1,019
Calgary, Edmonton, Lethbridge, Kelowna, New Westminster, Victoria, Moncton, Hamilton
2023-06-09
Active, closed
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
NCT05610319Diabetic Macular Edema
DrugFaricimab
McMaster University
Phase 4
446
Calgary, New Westminster, Vancouver, Hamilton, London, Ottawa, Toronto, Montreal
2023-05-01
Active, closed
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869Atrial Fibrillation
DrugsMilvexian·Apixaban
Janssen Research & Development, LLC
Phase 3
20,284
Calgery, Edmonton, New Westminster, Surrey, Victoria, Halifax, Brampton, Cambridge
2023-04-11
Active, closed
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034Ischemic Stroke; Ischemic Attack, Transient
DrugMilvexian
Janssen Research & Development, LLC
Phase 3
12,523
Calgary, Edmonton, Lethbridge, Medicine Hat, New Westminster, Vancouver, Brandon, Winnipeg
2023-02-15
Recruiting
Aggressive Smoking Cessation Trial (ASAP)
NCT05257629Acute Coronary Syndrome, Cardiovascular Diseases
Sir Mortimer B. Davis - Jewish General Hospital
Phase 3
798
New Westminster, Moncton, St. John's, Halifax, London, Ottawa, Toronto, Montreal
2023-02-02
Active, closed
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304Ischemic Stroke, Systemic Embolism
AtriCure, Inc.
Not applicable
6,573
Calgary, Edmonton, New Westminster, Saint John, Halifax, Hamilton, Kingston, London
2023-01-25
Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
NCT05624450Viral Lung Infection and Acute Respiratory Failure
DrugTozorakimab
AstraZeneca
Phase 3
3,527
Calgary, New Westminster, Winnipeg, Brampton, Ottawa, Toronto, Lévis, Montreal
2022-12-13
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
New Westminster, Don Mills, Hamilton, London, Ottawa, Vaughan, Boisbriand, Montreal
2022-11-21
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05242484Colitis, Ulcerative
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
577
Calgary, Edmonton, New Westminster, Vancouver, Victoria, Winnipeg, Dartmouth, Halifax
2022-09-19
Active, closed
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05528510Colitis, Ulcerative
DrugsGuselkumab 1·Guselkumab 2·Guselkumab 3
Janssen Research & Development, LLC
Phase 3
418
New Westminster, Barrie, Saskatoon
2022-09-13
Recruiting
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
NCT05246098Respiratory Disease, COVID-19, Viral Infection
McMaster University
Observational
900
Calgary, Edmonton, St. Albert, New Westminster, Winnipeg, Halifax, Brantford, Hamilton
2022-08-24
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471Crohn's Disease
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
703
Calgary, Edmonton, New Westminster, Vancouver, Victoria, Winnipeg, Dartmouth, Halifax
2022-07-22
Recruiting
Study Comparing SBS and LRTI for Treatment of CMC Arthritis
NCT05111405Arthritis
Fraser Orthopaedic Research Society
Not applicable
138
Calgary, New Westminster
2022-06-20
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Calgary, Edmonton, New Westminster, Vancouver, Etobicoke, Ottawa, Toronto, Québec
2022-01-13
By invitation
Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting
NCT04451044Coronary Artery Disease, Ischemic Heart Disease
Philips Clinical & Medical Affairs Global
Not applicable
3,212
New Westminster, Montreal, Brampton, Toronto
2021-06-17
Recruiting
Static Helical Screw Locking of Pertrochanteric Femur Fractures Using the TFN-A
NCT04851509Pertrochanteric Fracture
Fraser Orthopaedic Research Society
Not applicable
218
New Westminster
2021-05-17
Recruiting
Strength After Elbow Fractures in the Elderly
NCT05135949Fracture;Elbow
Fraser Orthopaedic Research Society
Observational
50
New Westminster
2021-02-22
Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
NCT04634240Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
University of British Columbia
Not applicable
4,000
Edmonton, New Westminster, Vancouver, Winnipeg, Saint John, Halifax, Hamilton, Ottawa
2020-12-19
Active, closed
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
NCT04524611Crohn's Disease (CD)
DrugsSkyrizi·Risankizumab·Ustekinumab
AbbVie
Phase 3
527
Calgary, Edmonton, New Westminster, Victoria, Halifax, London, North Bay, Toronto
2020-09-30
Active, closed
STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon
NCT03935750Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Reconstruction, Joint Instability
University of Pittsburgh
Not applicable
1,272
Banff, Calgary, New Westminster, Winnipeg, Halifax, Hamilton, London, Ottawa
2020-07-28
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
NCT04239573Pancreatic Neoplasm
ECOG-ACRIN Cancer Research Group
Observational
770
New Westminster, Hamilton, Kingston, Toronto
2020-06-16
Active, closed
Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium
NCT03928236Delirium, Post-cardiac Surgery
Population Health Research Institute
Not applicable
15,886
Edmonton, New Westminster, Vancouver, Winnipeg, Halifax, Hamilton, Kingston, London
2019-11-18
Active, closed
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NCT03735667Aortic Stenosis
Boston Scientific Corporation
Not applicable
1,948
New Westminster, Vancouver, London, Toronto, Montreal, Québec
2019-06-10
Active, closed
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
NCT03398135Ulcerative Colitis (UC)
DrugsSkyrizi·Risankizumab
AbbVie
Phase 3
1,242
Calgary, Edmonton, New Westminster, Victoria, London, North Bay, Vaughan, Lévis
2018-08-28
Active, closed
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
NCT03519945Ulcerative Colitis
DrugMirikizumab
Eli Lilly and Company
Phase 3
1,058
Greenfield Park, London, Montreal, New Westminster, Vancouver, Victoria
2018-07-18
Active, closed
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411Crohn's Disease
DrugsGuselkumab 1·Guselkumab 2·Guselkumab 3·Ustekinumab
Janssen Research & Development, LLC
Phase 2/3
1,409
Calgary, Edmonton, New Westminster, Winnipeg, Barrie, London, Toronto, Waterloo
2018-04-13
Active, closed
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
NCT03105102Crohn's Disease
DrugsSkyrizi·Risankizumab
AbbVie
Phase 3
1,336
Calgary, Edmonton, New Westminster, Vancouver, Victoria, Halifax, Greater Sudbury, Hamilton
2018-04-09
Active, closed
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
NCT03345823Crohn's Disease
DrugUpadacitinib
AbbVie
Phase 3
747
Calgary, Edmonton, New Westminster, Vancouver, Halifax, Greater Sudbury, London, North Bay
2018-03-21
Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
NCT03242642Mitral Valve Regurgitation
Medtronic Cardiovascular
Not applicable
1,056
New Westminster, Vancouver, Toronto, Montreal
2017-10-23
Active, closed
LEADERS FREE II: BioFreedom™ Pivotal Study
NCT02843633Acute Coronary Syndrome, High Bleeding Risk
Biosensors Europe SA
Not applicable
1,203
Edmonton, New Westminster, Vancouver, Victoria, Hamilton, Ottawa, Montreal, Québec
2017-02-14
Active, closed
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
NCT02808780Ulcerative Colitis
Janssen Biotech, Inc.
Observational
535
New Westminster, Vancouver, Oshawa, Ottawa
2016-12-16
Active, closed
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
NCT01848561Ulcerative Colitis (UC)
AbbVie
Observational
8,250
Edmonton, New Westminster, Surrey, Vancouver, Victoria, Fredericton, Halifax, Brampton
2013-04-29
Active, closed
Multicenter ACL Revision Study (MARS)
NCT00625885Rupture of Anterior Cruciate Ligament
Vanderbilt University Medical Center
Observational
1,234
New Westminster, London
2006-03-26
Rows per page Showing 1–70 of 70
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-canada/city/new-westminster

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,540 studies in total at the last sync on 26 Sep 2026, 19:55 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 70 of those studies with a site in New Westminster.

How many clinical trials are recruiting in New Westminster?

32 of the 70 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:55 UTC sync. A further 3 have not yet opened recruitment, 33 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (New Westminster), 70 studies
PhaseStudiesRecruitingShare
Phase 3271338.6%
Not applicable15621.4%
Observational15621.4%
Phase 28411.4%
Phase 4324.3%
Phase 2/3101.4%
Phase EARLY_PHASE1111.4%

Most active sponsors

Lead sponsors with the most studies (New Westminster)
Lead sponsorStudiesRecruiting
AbbVie80
Janssen Research & Development, LLC60
Fraser Orthopaedic Research Society44
AstraZeneca33
McMaster University32
University of British Columbia31
University of Calgary32
Boehringer Ingelheim22
Eli Lilly and Company20
Fraser Health22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.